Company Filing History:
Years Active: 2017
Title: Valeria Alcon: Innovator in Recombinant Bacterium Technology
Introduction
Valeria Alcon is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant bacteria for immunological applications. Her innovative work has the potential to advance therapeutic strategies against various diseases.
Latest Patents
Valeria Alcon holds a patent for her invention titled "Recombinant bacterium and uses thereof." This invention relates to a recombinant bacterium that expresses an antigen translocated to the cytosol of a host organism. The recombinant bacterium comprises a nucleic acid encoding an antigen that utilizes the Type III secretion system for translocation. This technology is particularly relevant for intracellular pathogens that reside in the phagosome and do not induce rapid T cell activation. The translocated antigen can be a viral, bacterial, or tumor antigen, and methods for imparting immunity using this recombinant bacterium are also included in her patent.
Career Highlights
Valeria Alcon is affiliated with the National Research Council of Canada, where she continues to push the boundaries of scientific research. Her work is characterized by a commitment to innovation and excellence in the field of biotechnology.
Collaborations
Valeria collaborates with esteemed colleagues such as Subash Sad and Lakshmi Krishnan, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Valeria Alcon's contributions to recombinant bacterium technology exemplify her dedication to advancing medical science. Her innovative patent and collaborative efforts position her as a key figure in the field of biotechnology.